Αποτελέσματα Αναζήτησης
4 Ιαν 2023 · Sunlenca is the first of a new class of drugs called capsid inhibitors to be FDA-approved for treating HIV-1. Sunlenca works by blocking the HIV-1 virus’ protein shell (the capsid), thereby interfering with multiple essential steps of the viral lifecycle.
27 Ιαν 2021 · CABENUVA, a 2-drug co-packaged product of cabotegravir, a human immunodeficiency virus type-1 (HIV-1) integrase strand transfer inhibitor (INSTI), and rilpivirine, an HIV-1 non-nucleoside reverse...
6 Μαρ 2024 · A twice-yearly injectable formulation (Sunlenca) was approved in 2022 for treatment-experienced people with multidrug-resistant HIV. Gilead also makes a 300mg lenacapavir pill that is taken as an initial loading dose and can be used for temporary ‘bridging’ if an injection must be missed.
18 Νοε 2021 · Thousands of people with HIV will now be offered a new long-acting injection to manage their condition if they would prefer to stop taking daily pills. Charities have welcomed the approval of the...
23 Δεκ 2021 · The Food and Drug Administration this week approved an injectable drug that helps prevent the spread of HIV. It only has to be taken once every eight weeks, compared to a daily oral pill.
21 Ιαν 2021 · The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type...
23 Δεκ 2021 · The Food and Drug Administration has approved a new drug in the fight against AIDS. It's the first injectable medication for HIV prevention. NPR's global health correspondent Jason Beaubien...
